J&J and Roche are the strongest companies in the biopharma industry, says S&P Global

Johnson & Johnson and Roche are at the top of S&P Global’s pharmaceutical industry power ratings, which assess the strength of the world’s top 17 drugmakers.

To come up with the ranking, S&P considered a variety of measurement tools including competitive advantage, prospects for sustaining revenue growth, operating efficiency, scale, scope and diversification. In its analysis, S&P distills these factors into two categories—business risk and financial risk—to determine its ratings.